Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
Quest Diagnostics Inc DGX
News
Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026
Diagnostic-Testing Stocks Slide After Proposed Cuts to Medicare Payments for Lab Services
Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics
Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
Apple Health app Users to be Able to Order Labs from Quest Diagnostics
Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook
Quest Diagnostics Declares Quarterly Cash Dividend
Digi Power X to Announce 2026 Q2 Financial Results and Provide Operations Update on August 14th
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
Digi Power X Provides Operations and Financial Update
The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy?
United States